Elsevier MDL to Build New Electronic Lab Notebook for Life Sciences Research; MDL Isentris Technology Will Enable a New-Generation ELN That Aids R&D.SAN LEANDRO San Leandro (săn lēăn`drō), city (1990 pop. 68,223), Alameda co., W Calif., on San Francisco Bay; inc. 1872. Metal, wood, and paper products; chemicals; leather goods; foods and beverages; medical equipment; lighting fixtures; and , Calif. -- In response to industry and customer demand, Elsevier MDL Elsevier MDL is a subsidiary of Elsevier. It develops programs that aid in "discovery informatics", or the use of computers modeling of scientific information in ways that lead to new discoveries. The company was founded as Molecular Design Limited in 1978. has launched a dedicated, phased program to build a robust, scalable, enterprise-strength electronic laboratory notebook (ELN Noun 1. ELN - a Marxist terrorist group formed in 1963 by Colombian intellectuals who were inspired by the Cuban Revolution; responsible for a campaign of mass kidnappings and resistance to the government's efforts to stop the drug trade; "ELN kidnappers target ) for the life sciences, built on MDL MDL - (Originally "Muddle"). C. Reeve, Carl Hewitt and Gerald Sussman, Dynamic Modeling Group, MIT ca. 1971. Intended as a successor to Lisp, and a possible base for Planner-70. Basically LISP 1.5 with data types and arrays. (R) Isentris(R) technology, for delivery in 2006. "Elsevier MDL pioneered the first all-electronic laboratory notebook over a decade ago and is today a leader in the development and deployment of advanced ELN systems that combine the best features of paper notebooks with robust electronic data handling capabilities," said Elsevier MDL CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Lars Barfod. "A new generation ELN that satisfies both intellectual property and regulatory requirements is a unifying application that will significantly reduce cycle time in biopharmaceutical R&D." Biopharma researchers engaged in experiment planning and data capture/analysis supporting parallel synthesis, single- and multi-step reactions and other complex processes are increasingly demanding an electronic laboratory data capture, report generation, auditing, tracking and storage solution that supports FDA- and OSHA-mandated Good Manufacturing and Good Laboratory Practices, as well as 21 CFR CFR See: Cost and Freight Part 11 compliance. An integrated ELN system offers many productivity benefits: streamlining workflows, automating repetitive tasks, documenting discovery history for patent disclosure and defense and leveraging past work. In addition, an integrated ELN ensures that information captured in the system can benefit everyone in an R&D organization. The open, scalable, extensible and proven MDL Isentris discovery informatics platform offers the technology framework for building and delivering a variety of ELNs. The first ELN release will address the needs of discovery scientists, particularly in organic synthetic chemistry, with a scope encompassing authentication, sign/witness, audit, notebook record repository and reporting services with extensive workflow customization capabilities. The first release will integrate with MDL structure and reaction registration services, with the MDL(R) Discovery Logistics materials management Materials management is the branch of logistics that deals with the tangible components of a supply chain. Specifically, this covers the acquisition of spare parts and replacements, quality control of purchasing and ordering such parts, and the standards involved in ordering, solution, and with both Elsevier MDL and proprietary customer content. The first ELN will also support collaborative searching of hosted content via the DiscoveryGate(R) platform for scientific research. Subsequent ELN releases will provide additional functionality supporting development chemistry and biology workflows. Elsevier MDL offers extensive experience in developing and delivering ELN consulting applications, deep domain knowledge in chemistry and biology workflows, a large existing biopharmaceutical customer base and a corporate commitment to the pharmaceutical and wider scientific marketplaces. For all of these reasons, Elsevier MDL is positioned to exert a significant presence in the rapidly emerging ELN market. With the release of the new ELN, current Elsevier MDL customers using the existing MDL(R) Elan application will have the option to implement a modern, new generation ELN solution. Elsevier MDL is interested in working with customers to identify specific requirements for the new-generation ELN. Research organizations with an interest in defining and validating these requirements should contact an Elsevier MDL Account Manager. About Elsevier MDL Elsevier MDL provides informatics, database and workflow solutions that accelerate the discovery and development of successful new drugs by improving the speed and quality of scientists' decision making. Commercial, academic and government life sciences researchers around the world depend on Elsevier MDL for innovative and reliable discovery informatics software solutions and services augmented by 400 Elsevier chemistry and life sciences journals and related products. For more information, visit www.mdl.com. Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, the company publishes more than 1,800 journals and 2,200 new books per year, in addition to offering a suite of innovative electronic products and online reference works. For more information, visit www.elsevier.com. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Reed Elsevier's ticker symbols are REN ren or jen In Confucianism, the most basic of all virtues, variously translated as “humaneness” or “benevolence.” It originally denoted the kindness of rulers to subjects. (Euronext Amsterdam), REL (London Stock Exchange London Stock Exchange London marketplace for securities. It was formed in 1773 by a group of stockbrokers who had been doing business informally in local coffeehouses. ), RUK RUK Reserviupseerikoulu (Hamina, Finland, Reserve Officers' School) RUK Are You Kidding? and ENL Noun 1. ENL - an inflammatory complication of leprosy that results in painful skin lesions on the arms and legs and face erythema nodosum leprosum Hansen's disease, leprosy - chronic granulomatous communicable disease occurring in tropical and subtropical (New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. ). For more information, visit www.reedelsevier.com. MDL, Isentris and DiscoveryGate are registered trademarks of MDL Information Systems, Inc. ('Elsevier MDL') in the United States and/or other countries. All rights reserved. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion